Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Jornal de Pediatria

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JPEDS.2005.04.016PMID 16126043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for treatment of candidiasis.

  2004cited by this paper
• Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis

  2004cited by this paper
• RESISTANT CANDIDA PARAPSILOSIS ASSOCIATED WITH LONG TERM FLUCONAZOLE PROPHYLAXIS IN AN ANIMAL MODEL

  2004cited by this paper
• Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection.

  2004cited by this paper
• Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants.

  2004cited by this paper
• Empirical therapy for neonatal candidemia in very low birth weight infants.

  2003cited by this paper
• Early Bubble CPAP and Outcomes in ELBW Preterm Infants

  2003cited by this paper
• Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.

  2002cited by this paper
• Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.

  2001cited by this paper
• Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia.

  2001cited by this paper
• Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant.

  2001cited by this paper
• Fluconazole prophylaxis against fungal colonization and infection in preterm infants.

  2001cited by this paper
• Persistently positive cultures and outcome in invasive neonatal candidiasis

  2000cited by this paper
• Risk factors for candidemia in Neonatal Intensive Care Unit patients

  2000cited by this paper
• Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases.

  1998cited by this paper
• Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network.

  1996cited by this paper
• Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network.

  1996cited by this paper
• Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life

  1993cited by this paper
• Candida: an increasingly important pathogen in the nursery.

  1988cited by this paper

• Candidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment

  2025cites this paper
• Invasive Candida Infections in Neonatal Intensive Care Units: Risk Factors and New Insights in Prevention

  2024cites this paper
• Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants

  2022cites this paper
• Invasive Candida Infections in Neonates after Major Surgery: Current Evidence and New Directions

  2021cites this paper
• Therapeutic drug monitoring for antifungal triazoles: pharmacologic background and current status

  2020cites this paper
• Fluconazole prophylaxis against invasive candidiasis in very low and extremely low birth weight preterm neonates: a systematic review and meta-analysis

  2020cites this paper
• Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population

  2020cites this paper
• Efficacy of Fluconazole Prophylaxis on Invasive Candidiasis Infection in Extremely Low Birth Weight Neonates

  2020cites this paper
• The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species

  2019cites this paper
• Antifungal Susceptibility Profiles of Candida Species Isolated from Ahvaz Jundishapur Educational Hospitals

  2018cites this paper
• Health Care-Associated Infections

  2018cites this paper
• Candiduria en pacientes hospitalizados: etiología, sensibilidad a los fármacos antifúngicos y factores de riesgo

  2018cites this paper
• Candiduria: Evidence-based approach to management, are we there yet?

  2017cites this paper
• Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries

  2017cites this paper
• Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial

  2016cites this paper
• Cost Analysis of Fluconazole Prophylaxis for Prevention of Neonatal Invasive Candidiasis

  2016cites this paper
• Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

  2016cites this paper
• Evaluation and Optimization of a Serum-based Minimum Inhibitory Concentration Assay to Caspofungin in Candida albicans Clinical Isolates

  2016cites this paper
• Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta-analysis of randomized controlled trials

  2016influential citation
• Advances in the treatment of invasive neonatal candidiasis

  2015cites this paper
• Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

  2015cites this paper
• Integrated measures for prevention of invasive Candida infections in preterm infants in a Chinese neonatal intensive care unit.

  2015cites this paper
• Fluconazole prophylaxis for prevention of invasive candidiasis in infants

  2014cites this paper
• Candiduria: Epidemiology, Resistance, Classical and Alternative Antifungals Drugs

  2014cites this paper
• Candiduria : Epidemiology , Resistance , Classical and Alternative Antifungal Drugs

  2014cites this paper
• Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants Jessica K. RobertsChris StockmannJonathan E. Constance • Justin StiersMichael G. SpigarelliRobert M. Ward •

  2014cites this paper
• Efficacy of Prophylactic Fluconazole Therapy in Decreasing the Incidence of Candida Infections in Extremely Low Birth Weight Preterm Infants

  2014cites this paper
• Changes in the Incidence of Candidiasis in Neonatal Intensive Care Units

  2014cites this paper
• Neonatal sepsis: progress towards improved outcomes.

  2014cites this paper
• Efficacy of Fluconazole Prophylaxis for Invasive Fungal Infection in Extremely Low Birth Weight Infants

  2014cites this paper
• Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants

  2014cites this paper
• Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

  2013cites this paper
• Recent Developments and Current Issues in the Epidemiology, Diagnosis, and Management of Bacterial and Fungal Neonatal Sepsis

  2013cites this paper
• Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.

  2013cites this paper
• Impact of ‘targeted’ fluconazole prophylaxis for preterm neonates: efficacy of a highly selective approach?

  2012cites this paper
• A review of Candida prophylaxis in the neonatal intensive care population.

  2012cites this paper
• Treatment and prophylaxis of invasive candidiasis.

  2012cites this paper
• The use of antifungal therapy in neonatal intensive care.

  2012cites this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

  2012cites this paper
• "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.

  2012cites this paper
• Chapter 17 – Neonatal Fungal Infections

  2012cites this paper
• Trends in Candida Central Line-Associated Bloodstream Infections Among NICUs, 1999–2009

  2012cites this paper
• Chapter 40 – Health Care–Acquired Infections in the Nursery

  2012cites this paper
• Strategies for the prevention of neonatal candidiasis.

  2012cites this paper
• Quality and Safety in PICU and NICU: Scoreboard Control and Care Network

  2011cites this paper
• Aiming for Zero: Preventing Invasive Candida Infections in Extremely Preterm Infants

  2011cites this paper
• Candida Infections of the Genitourinary Tract

  2010cites this paper
• Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study.

  2010cites this paper
• Recently tested strategies to reduce nosocomial infections in the neonatal intensive care unit

  2010cites this paper
• CATHETER-RELATED BACTEREMIA CAUSED BY METHICILLIN-RESISTANT COAGULASE NEGATIVE STAPHYLOCOCCI WITH ELEVATED MINIMAL INHIBITORY CONCENTRATION FOR VANCOMYCIN

  2010cites this paper
• Epidemiology and prevention of neonatal candidiasis: fluconazole for all neonates?

  2010cites this paper
• IMPACT OF ROUTINE FLUCONAZOLE PROPHYLAXIS FOR PREMATURE INFANTS WITH BIRTH WEIGHTS OF LESS THAN 1250 GRAMS IN A DEVELOPING COUNTRY

  2010cites this paper
• Fluconazole to Prevent Systemic Fungal Infections in Infants: Reviewing the Evidence

  2010cites this paper
• Clinical microbiology of neonatal candidiasis in Hungary.

  2010cites this paper
• Review Challenging issues in neonatal candidiasis

  2010cites this paper
• Strategies to prevent invasive candidal infection in extremely preterm infants.

  2010cites this paper
• Challenging issues in neonatal candidiasis

  2010cites this paper
• Fluconazole Prophylaxis in High-Risk Neonates

  2010cites this paper
• Efficacy of Fluconazole Prophylaxis for Prevention of Invasive Fungal Infection in Extremely Low Birth Weight Infants

  2009cites this paper
• 14 – Infecciones por hongos e infestaciones e infecciones parasitarias en neonatos

  2009cites this paper
• Comparison of Fluconazole and Nystatin Oral Suspensions for Prophylaxis of Systemic Fungal Infection in Very Low Birthweight Infants

  2009cites this paper
• The use of fluconazole in neonatal intensive care units

  2009cites this paper
• Fluconazole prophylaxis in the neonatal intensive care unit.

  2009cites this paper
• Infants: Yeasts are beasts in early life

  2009cites this paper
• Why prevent Invasive Candida Infections?

  2008cites this paper
• Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?

  2008cites this paper
• Prevention of invasive Candida infections in preterm infants: the time is now

  2008cites this paper
• First, Do No Harm

  2008cites this paper
• THE ROLE OF CANDIDA SURVEILLANCE CULTURES FOR IDENTIFICATION OF A PRETERM SUBPOPULATION AT HIGHEST RISK FOR INVASIVE FUNGAL INFECTION

  2008cites this paper
• Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?

  2008cites this paper
• Fungal Infections, Infestations and Parasitic Infections in Neonates

  2008cites this paper
• NATIONWIDE SURVEY OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS PREVENTION IN JAPANESE CHILDREN WITH CONGENITAL HEART DISEASE

  2008cites this paper
• Healthcare-Associated Infections in Pediatrics

  2008cites this paper
• Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure

  2008cites this paper
• Neonatal Candida spp. infections: an update

  2008cites this paper
• Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant Candida Species

  2008cites this paper
• Fungal Prophylaxis in the Neonatal Intensive Care Unit

  2008cites this paper
• Hospital-acquired infections in the NICU: epidemiology for the new millennium.

  2008cites this paper
• Antifungal prophylaxis for the prevention of neonatal candidiasis?

  2008cites this paper
• Capítulo 6 – Infecciones por hongos y levaduras de la piel

  2008cites this paper
• Chapter 15 – Neonatal Fungal Infections

  2008cites this paper
• Fungal and Yeast Infections of the Skin

  2007cites this paper
• Use of Lactobacillus casei Subspecies Rhamnosus GG and Gastrointestinal Colonization by Candida Species in Preterm Neonates

  2007cites this paper
• A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.

  2007cites this paper
• Antifungal therapy for neonatal candidiasis

  2007cites this paper
• Empfehlung zur Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1500 g

  2007cites this paper
• Candidal versus bacterial late-onset sepsis in very low birthweight infants in Israel: a national survey.

  2007cites this paper
• Clinical pharmacology of antifungal agents in pediatric patients

  2007cites this paper
• Invasive fungal infections in children: advances and perspectives

  2007cites this paper
• Fluconazole prophylaxis in high-risk, very low birth weight infants

  2007cites this paper
• Prophylactic fluconazole in preterm neonates.

  2007cites this paper
• Antifungal Agents in Neonates

  2007cites this paper
• Prevention and treatment of Candida infections in neonates.

  2007cites this paper
• Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

  2007cites this paper
• Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection

  2007cites this paper
• Neonatal Fungal Infections: The State of the Art

  2007cites this paper
• Prophylactic fluconazole in preterm neonates.

  2007cites this paper
• Spécificités pédiatriques de l’utilisation des antifongiques

  2006cites this paper
• Patterns of Fungal Colonization in Preterm Infants Weighing Less Than 1000 Grams at Birth

  2006cites this paper
• Veronate (Inhibitex).

  2006cites this paper